A Study of Idazoxan in Healthy Participants

Launched by TERRAN BIOSCIENCES AUSTRALIA PTY LTD · Feb 3, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a medication called Idazoxan in healthy adults to find out how safe it is and how the body processes it. The trial has four parts and involves testing different forms of the medication. Researchers want to ensure that it is well-tolerated and to gather important information about how it works in the body.

To participate in this trial, you need to be between 18 and 65 years old and have a body mass index (BMI) between 18 and 32, which is a measure of your weight in relation to your height. You should be in good health without any serious medical conditions. If you are interested in joining, you will be asked to go through some health screenings to make sure you meet the criteria. During the trial, participants will take the medication and be monitored for safety and any side effects. It's important to note that those who are taking certain medications, have kidney or heart issues, or have a history of substance use will not be eligible to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • BMI between 18 and 32 kg/m2
• • Medically healthy without clinically significant or relevant medical history
• Exclusion Criteria:
• • Evidence of recurrent disease, physical illness or medical condition that could affect action, absorption or disposition of investigational products
• • Use of any prescription or over-the-counter medication that cannot be discontinued for the duration of the study
• • Impaired renal function
• • Cardiac abnormalities
• • Positive HIV, HBsAg or HCV
• • Positive test for alcohol, drugs of abuse or cotinine